iShares U.S. Pharmaceuticals ETF · Other
3m RS is unavailable, Market Stance is 47.8
As of 2026-08-24, iShares U.S. Pharmaceuticals ETF (IHE) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Other. Average daily range 1.6%, relative volume 0.55×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | JNJ | 23.03% | $230M |
| 2 | LLY | 21.06% | $211M |
| 3 | MRK | 4.74% | $47M |
| 4 | PFE | 4.71% | $47M |
| 5 | RPRX | 4.70% | $47M |
| 6 | BMY | 4.63% | $46M |
| 7 | ZTS | 4.52% | $45M |
| 8 | VTRS | 4.35% | $43M |
| 9 | ELAN | 3.32% | $33M |
| 10 | JAZZ | 3.21% | $32M |
| 11 | AXSM | 2.00% | $20M |
| 12 | Terns Pharmaceuticals Inc | 1.27% | $13M |
| 13 | LGND | 1.10% | $11M |
| 14 | INDV | 1.06% | $11M |
| 15 | CORT | 1.05% | $11M |
| 16 | CRNX | 1.04% | $10M |
| 17 | SUPN | 0.83% | $8M |
| 18 | PBH | 0.78% | $8M |
| 19 | TARS | 0.77% | $8M |
| 20 | LQDA | 0.72% | $7M |
| 21 | EWTX | 0.65% | $7M |
| 22 | AMRX | 0.59% | $6M |
| 23 | NKTR | 0.56% | $6M |
| 24 | DFTX | 0.52% | $5M |
| 25 | ALMS | 0.50% | $5M |
Showing 25 of 56 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
Daily range, ATR, beta, and the math for a 1-ADR stop.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IHE Jan avg: 2.62% median: 2.56% win: 75% σ: 2.46% n: 4 2022-04-12 → 2026-07-31 | IHE Feb avg: 3.05% median: 5.30% win: 75% σ: 5.49% n: 4 2022-04-12 → 2026-07-31 | IHE Mar avg: -2.24% median: -1.69% win: 25% σ: 2.59% n: 4 2022-04-12 → 2026-07-31 | IHE Apr avg: -1.92% median: -3.43% win: 40% σ: 3.97% n: 5 2022-04-12 → 2026-07-31 | IHE May avg: 0.22% median: 2.62% win: 60% σ: 4.70% n: 5 2022-04-12 → 2026-07-31 | IHE Jun avg: 2.48% median: 0.88% win: 80% σ: 3.69% n: 5 2022-04-12 → 2026-07-31 | IHE Jul avg: 1.41% median: 1.75% win: 80% σ: 1.51% n: 5 2022-04-12 → 2026-07-31 | IHE Aug avg: 2.87% median: 5.41% win: 75% σ: 7.16% n: 4 2022-04-12 → 2026-07-31 (current) | IHE Sep avg: -2.89% median: -3.42% win: 25% σ: 3.60% n: 4 2022-04-12 → 2026-07-31 | IHE Oct avg: 0.99% median: 1.27% win: 50% σ: 5.71% n: 4 2022-04-12 → 2026-07-31 | IHE Nov avg: 5.21% median: 4.12% win: 100% σ: 5.14% n: 4 2022-04-12 → 2026-07-31 | IHE Dec avg: -0.17% median: -0.64% win: 25% σ: 4.42% n: 4 2022-04-12 → 2026-07-31 |
Metrics matched 53 tickers across 56 holdings rows (97.9% of fund weight). Metrics as of 2026-08-24; holdings from the filing.
Holdings of IHE currently on TickerStance stock-RS leaderboards.
| 0.21% |
| 1Y RS |
| 41 |
| Stage 2 |